LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Partnership Dren Bio, Inc. recently secured a $3 billion agreement with Novartis Pharma to develop bispecific antibodies for cancer, indicating a substantial sales opportunity through collaboration and joint research and development efforts.

Financial Injection With recent equity investments totaling $175 million from Novartis, including a $25 million upfront payment, Dren Bio has the financial resources to explore new sales avenues and expand its offerings, presenting a window for potential sales pitches and partnerships.

Elite Hiring Dren Bio strengthened its leadership team by appointing Dr. Amit Mehta as the Chief Operating Officer and Chief Business Officer, showcasing a strategic move towards bolstering business operations and potentially opening doors to new sales channels and market expansion.

Top Talent Acquisition The departure of Dr. Will as the Chief Medical Officer and subsequent move to Autolus signifies a potential opportunity for Dren Bio to attract top talent for key roles, fostering new partnerships, and leveraging industry expertise for enhanced sales strategies.

Innovative Product Development Dren Bio's development of novel Targeted Myeloid engagers for cancer, in collaboration with Novartis, presents a cutting-edge solution that can create buzz in the market and attract interest from potential buyers looking for innovative treatment options.

Similar companies to Dren Bio, Inc.

Dren Bio, Inc. Tech Stack

Dren Bio, Inc. uses 8 technology products and services including cdnjs, Font Awesome, Ionicons, and more. Explore Dren Bio, Inc.'s tech stack below.

  • cdnjs
    Content Delivery Network
  • Font Awesome
    Font Scripts
  • Ionicons
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Highlight.js
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • Adobe Creative Suite
    Visualisation Software

Media & News

Dren Bio, Inc.'s Email Address Formats

Dren Bio, Inc. uses at least 1 format(s):
Dren Bio, Inc. Email FormatsExamplePercentage
FLast@drenbio.comJDoe@drenbio.com
50%
FLast@drenbio.comJDoe@drenbio.com
50%

Frequently Asked Questions

Where is Dren Bio, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Dren Bio, Inc.'s main headquarters is located at 384 Foster City Blvd Foster City, California 94404 US. The company has employees across 4 continents, including North AmericaEuropeAfrica.

What is Dren Bio, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Dren Bio, Inc.'s official website is drenbio.com and has social profiles on LinkedIn.

How much revenue does Dren Bio, Inc. generate?

Minus sign iconPlus sign icon
As of September 2024, Dren Bio, Inc.'s annual revenue reached $3.8M.

What is Dren Bio, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Dren Bio, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dren Bio, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2024, Dren Bio, Inc. has approximately 74 employees across 4 continents, including North AmericaEuropeAfrica. Key team members include Chief Executive Officer: N. T.Chief Operating Officer And Chief Business Officer: A. M.Chief Medical Officer: M. W.. Explore Dren Bio, Inc.'s employee directory with LeadIQ.

What industry does Dren Bio, Inc. belong to?

Minus sign iconPlus sign icon
Dren Bio, Inc. operates in the Biotechnology Research industry.

What technology does Dren Bio, Inc. use?

Minus sign iconPlus sign icon
Dren Bio, Inc.'s tech stack includes cdnjsFont AwesomeIoniconsjQuery MigratejQueryHighlight.jsOWL CarouselAdobe Creative Suite.

What is Dren Bio, Inc.'s email format?

Minus sign iconPlus sign icon
Dren Bio, Inc.'s email format typically follows the pattern of . Find more Dren Bio, Inc. email formats with LeadIQ.

How much funding has Dren Bio, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2024, Dren Bio, Inc. has raised $25M in funding. The last funding round occurred on Jul 24, 2024 for $25M.
Dren Bio, Inc.

Dren Bio, Inc.

Biotechnology ResearchCalifornia, United States51-200 Employees

Dren Bio is a Foster City, CA based biotechnology company, developing power protein-based technologies to deplete pathogenic cells and agents in numerous diseases.

Section iconCompany Overview

Headquarters
384 Foster City Blvd Foster City, California 94404 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $25M

    Dren Bio, Inc. has raised a total of $25M of funding over 5 rounds. Their latest funding round was raised on Jul 24, 2024 in the amount of $25M.

  • $10M

    Dren Bio, Inc.'s revenue is in the range of $10M

Section iconFunding & Financials

  • $25M

    Dren Bio, Inc. has raised a total of $25M of funding over 5 rounds. Their latest funding round was raised on Jul 24, 2024 in the amount of $25M.

  • $10M

    Dren Bio, Inc.'s revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.